Penggunaan Jamu pada Pasien Hiperlipidemia Berdasarkan Data Rekam Medik, di Beberapa Fasilitas Pelayanan Kesehatan di Indonesia

  • Retno Gitawati Pusat Teknologi Terapan Kesehatan dan Epidemiologi Klinik, Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan, Indonesia
  • Lucie Widowati Pusat Teknologi Terapan Kesehatan dan Epidemiologi Klinik, Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan, Indonesia
Keywords: Hyperlipidemia, Jamu, Guazumae folium, Murrayae folium

Abstract

Hyperlipidemias are disorders which are manifested by elevation of blood lipid, such as total cholesterol and/or triglyceride above the normal level. Hyperlipidemia management is done by lifestyle modification (high-fiber diet, exercises) as well as using antidyslipidemias. On the other hand, non-conventional or traditional treatment of hyperlipidemias using herbals (jamu) is becoming ubiquitous, performed by jamu practitioner clinician (dokter praktik jamu). This study is a part of a web-site Jamu Registry Study, which is intended to figure herbal (jamu) dispensed by jamu practitioner clinician for hyperlipidemic patients. A descriptive, cross-sectional design is applied, using medical record data of ‘jamu’ patients from some health facilities, in 7 provinces in Indonesia. Results showed, out of 97 hyperlipidemic patients were mostly female (60.8%), aged 48-58 years (46.4%); most of them (62.9%) were treated merely with jamu for 1 – 2 weeks, and the rests were treated with jamu in combination with conventional and/or other alternative medication. The most jamu used were branded herbal capsules (55.7%) containing of Guazumae folium and Murrayae folium. Adverse events were reported in four cases i.e. diarrhea and diuresis

References

1. Lecerf JM, de Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk. British Journal of Nutrition. 2011;106(1):6-14.
2. Sadik F. Hyperlipidemia, update & review. Volume 35 No 1 [internet]. Deerfiled:W-F Professional Associates; 2013 Jan [cited 2015 Jan 27] Diunduh dari: http://www. wfprofessional.com/ documents/Hyperlipidemia-1.13.pdf
3. Management of dyslipidemia 2011, the 4 th Edition of clinical practice guidelines [internet]. Putrajaya: Minitry of Health; 2011 [cited 2015 Jan 27]. Available from http://www.moh.gov.my/attachments/663 2.pdf. Jointly published with National Heart Assosiation of Malaysia and Academic of Medicine.
4. White LE. Xanthomatoses and lipoprotein disorder. In: Fitzpatrick TB, Wolff K, Goldsmith AL, Gilchrest AB, Paller SA, Leffell JD (editors). Dermatology in general medicine. 7th ed. New York: McGraw-Hill; 2008:1272-81.
5. Yalcinkaya U, Oztop F. Xanthoma of the calcaneus associated with hyperlipoproteinemia. Journal of the American Paediatric Medical Association. 2005;95 (6):602-4.
6. Dallari D, Marinelli A, Pellacani A, Valeriani L, Lesi C, Bertoni F, et al. Xanthoma of bone: First sign of hyperlipidemia type IIB: A case report. Clinical Orthopaedics and Related Research. 2003;410:274-7.
7. Badan Penelitian dan Pengembangan Kesehatan. Pokok-pokok hasil Riskesdas Indonesia tahun 2013. Buku 1. Jakarta: Kementerian Kesehatan RI; 2013.
8. Stang J, Story M, editors. Guidelines for adolescent nutrition services [Internet]. Minneapolis: School of Public Health, University of Minnesota; 2005. Available from http://www.epi.umn.edu/let/pubs/ adol_book.shtm.
9. Safeer RS, Lacivita CL. Choosing drug therapy for patients with hyperlipidemia. American Family Physician. 2000;61 (11):3371-82.
10. Antihyperlipidemic drugs. Diunduh 27 Januari 2015 dari: http://mlearning.zju. edu.cn/G2S/eWebEditor/uploadfile/2012 0529102107199.pdf
11. Delima, Widowati L, Astuti Y, Siswoyo H, Gitawati R, Purwadianto A. Gambaran praktik penggunaan jamu oleh dokter di enam provinsi di Indonesia. Buletin Penelitian Kesehatan. 2012;40(3):109-22.
12. Widowati L. Jamu registri. Badan Penelitian dan Pengembagan Kesehatan, Kementerian Kesehatan RI; 2014.
13. Widowati L, Siswanto, Delima, Siswoyo H. Evaluasi praktik dokter yang meresepkan jamu untuk pasien penderita penyakit degenerativ di 12 propinsi. Media Litbangkes. 2014;24(2):95-102.
14. Ellya RD, Sijani P, Utju R dan Edhiwan P. Dislipidemia pada kelompok usia lanjut di Lembang Bandung. Jurnal Kesehatan Masyarakat. 2001;1(1):39-53.
15. Kamso S, Purwantyastuti, Rumawas YSP dan Lukito W. Nutritional status of hyperlipidemics elderly in Indonesia according to body mass index (study in four Indonesian big cities). Medical Journal Indones. 2005;14:97-100.
16. Siswanto. Saintifikasi jamu sebagai upaya terobosan untuk mendapatkan bukti ilmiah. Buletin Penelitian Sistem Kesehatan. 2012;15(2): 203–11.
17. NCEP-ATP III Guidelines. Third report of the National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), Executive Summary, NIH, National Heart, Lung, and Blood Institute, May 2001.
18. Heyne K. Tumbuhan berguna. Jilid 1, terjemahan Badan Litbang Kehutanan, Koperasi Karyawan Departemen Kehutanan, Jakarta Pusat. 1987;601-2. Jurnal Kefarmasian Indonesia. 2015;5(1):41-48 48
19. Andriani Y. Pengaruh ekstrak daun jati belanda (Guazuma ulmifolia Lamk.) terhadap bobot badan kelinci yang diberi pakan berlemak. Jurnal Gradien. 2005;1(2):74-6.
20. Kristiani EBE. Ekstrak daun jati belanda (GuazumaUlmifolia Lamk.) sebagai obat alternatif untuk hiperlipidemia: kajian in vivo dan in vitro [Tesis]. Institut Pertanian Bogor, Program Studi Biokimia, Bogor; 2003.
21. Rachmadina. Ekstrak air daun jati belanda (Guazuma ulmifolia Lamk.) berpotensi menurunkan kadar lipid darah pada tikus putih strain Wistar. 2001 [Skripsi]. Institut Pertanian Bogor, FMIPA, Jurusan Kimia, Bogor; 2001.
22. Sawitri R. Pengaruh pemberian kombinasi ekstrak etanol daun jati belanda (Guazuma ulmifolia, L) dan kelopak bunga rosella (Hibiscus sabdarifa, L) terhadap kadar trigliserida pada tikus putih jantan [Skripsi], Fakultas Farmasi, Universitas Setia Budi, Surakarta; 2014.
23. Pramono S, Nurwati S, Sugiyanto. Pengaruh lendir daun jati belanda (Guazuma ulmifolia Lamk.) terhadap bobot badan tikus putih betina. Warta Tumbuhan Obat Indonesia. 2000; 6(2):14-5.
24. Hidayat M, Soeng S, Prahastuti S, Patricia TH, Yonathan KA. Aktivitas antioksidan dan antitrigliserida ekstrak tunggal kedelai, daun jati belanda serta kombinasinya. Bionatura-Jurnal Ilmuilmu Hayati dan Fisik. 2014;16(2):89-94.
25. Rahardjo SS, Ngatijan, Pramono S. Aktifitas lipase pancreas Rattus novergicus akibat pemberian ekstrak etanol daun jati belanda (Guazuma ulmifolia Lamk), Berkala Ilmu Kedokteran. 2005;38(1):15-23.
26. Rosdiana. Pengaruh ekstrak daun kemuning terhadap penurunan berat badan. Jurnal Penelitian UMJ. 2010; 16(3):15-29.
27. Paembonan IL. Efek serbuk daun kemuning (Murraya paniculata L.) terhadap penurunan kadar kolesterol LDL serum mencit jantan (Mus musculus) galur Swiss Webster yang diberi asupan tinggi kolesterol [Tesis]. Universitas Kristen Maranatha; 2012.
28. Badan Pengawas Obat dan Makanan RI. Taksonomi koleksi tanaman obat kebun tanaman obat Citeureup: Guazuma ulmifolia. Jakarta; 2008.
29. Royhan Rozqie, Maulina Diah, Woro Rukmi P. The effect of jati belanda (Guazuma ulmifolia Lamk) leaves extract on histopathology of rat’s kidney. Tropical Medicine Journal. 2012; 2(1):57-65.
Published
2015-02-17
How to Cite
1.
Gitawati R, Widowati L. Penggunaan Jamu pada Pasien Hiperlipidemia Berdasarkan Data Rekam Medik, di Beberapa Fasilitas Pelayanan Kesehatan di Indonesia. jki [Internet]. 17Feb.2015 [cited 20May2022];5(1):41-8. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/jki/article/view/3474
Section
Articles